on 23 Feb 2021
Last Applicant/ Owned by
Xintai 5th Rd., Xizhi Dist
New Taipei City
TW
221
Serial Number
88087944 filed on 22nd Aug 2018
Registration Number
6274912 registered on 23rd Feb 2021
Correspondent Address
Michael T. Smith
Filing Basis
1. intent to use
Disclaimer
NO DATA
Therapeutic pharmaceutical for the treatment of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Chemical preparations for pharmaceutical or medical purposes, namely, for treating neuropsychiatric disorders, namely, schizophrenia, depression, attention defici Read More
Therapeutic pharmaceutical for the treatment of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Chemical preparations for pharmaceutical or medical purposes, namely, for treating neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Chemical reagents for medical or veterinary purposes; Sodium salts for medical purposes
No 88087944
No Service/Collective Mark
No 6174-0135US1
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
23rd Feb 2021 | REGISTERED-PRINCIPAL REGISTER |
08th Dec 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
08th Dec 2020 | PUBLISHED FOR OPPOSITION |
18th Nov 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
30th Oct 2020 | 1(B) BASIS DELETED; NEW BASIS REQUESTED |
30th Oct 2020 | PETITION TO DIRECTOR - CHANGE BASIS - GRANTED |
30th Oct 2020 | NOTICE OF ALLOWANCE CANCELLED |
29th Oct 2020 | ASSIGNED TO PETITION STAFF |
12th Sep 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
10th Sep 2020 | EXTENSION 3 GRANTED |